P21

Originally developed as a nootropic compound, this synthetic peptide attempts to replicate the brain-boosting properties of naturally occurring BDNF without the delivery challenges that plague the native protein. Neuroscience researchers investigate P21 primarily for its potential to promote new brain cell formation and enhance memory consolidation. The peptide represents an early attempt to create pharmaceutically viable neurotrophin mimetics.

P21 works by binding to the same cellular receptors that respond to brain-derived neurotrophic factor, theoretically triggering the molecular cascades that promote neuron survival and growth. Unlike BDNF itself, which struggles to cross from blood into brain tissue, P21's smaller molecular structure may allow it to penetrate the blood-brain barrier more effectively. Once in neural tissue, it aims to activate the TrkB receptor pathway that governs synaptic plasticity and new neuron development.